VIE Equity Snapshot

ZEAL Weekly Equity Report

Zealand Pharma A/S

Interactive chart JSON snapshot
Latest Close 39.61 EUR 12 Jun 2026
1W Return -7.3% latest completed week
4W Return -5.1% short-term follow-through
12W Return - quarterly tape
Trend Breadth 0.0% 0 of 11 weeks active
Volume Ratio 1.3x vs 13-week average
Company Brief

What the company does

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical …

Snapshot

What the weekly tape is saying

ZEAL closed the latest completed week at 39.61 EUR. The 4-week return is -5.1% and the 12-week return is -. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Risk-first tape with a 37/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -
Volume 1.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 38 Blend of 4-week and 12-week follow-through.
Dynamics 50 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 56 Participation compared with the 13-week volume baseline.
Risk Control 30 Drawdown and recent weekly volatility pressure.

16-week signal tape

3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
-
Vs Trend Line
-
Fair Value
41.71 EUR
Vs Fair Value
-5.0%
52W High
48.50 EUR
52W Low
32.64 EUR
Drawdown
-18.3%
Range Position
43.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -7.3%
4W -5.1%
12W -
26W -
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
AT Healthcare
Sector Rank
109 of 112
Sector Percentile
2.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.00
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Undecided
Probability
48.26%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
12.7K
13W Average
9.5K
52W Average
9.5K
Vs 13W
1.3x
Vs 52W
1.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.5%
52W Volatility
7.5%
Upside Weeks
4
Downside Weeks
6
Downside Breadth
60.0%
Avg Gain / Loss
7.7% / -4.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
3.0B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The latest week was a sharp negative move.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 39.61 EUR -7.3% - 41.71 EUR 0.00 - 12.7K Off
5 Jun 2026 42.74 EUR -1.6% - 41.92 EUR 0.00 - 11.4K Off
29 May 2026 43.43 EUR 2.2% - 41.83 EUR 0.00 - 4.5K Off
22 May 2026 42.49 EUR 1.8% - 41.63 EUR 0.00 - 9.0K Off
15 May 2026 41.74 EUR -8.7% - 41.50 EUR 0.00 - 10.4K Off
8 May 2026 45.70 EUR 13.8% - 41.46 EUR 0.00 - 17.4K Off
1 May 2026 40.17 EUR -1.1% - 40.62 EUR 0.00 - 19.2K Off
24 Apr 2026 40.60 EUR -6.9% - 40.73 EUR 0.00 - 3.3K Off
17 Apr 2026 43.61 EUR 13.1% - 40.77 EUR - - 16.8K Off
10 Apr 2026 38.55 EUR -4.0% - 39.35 EUR - - 0 Off
3 Apr 2026 40.15 EUR - - 40.15 EUR - - 0 Off